MAPK1 and Huntington disease: This is consistent with a well‐established role for ERK downstream to BDNF–TrkB receptor activation in the striatum (Cunha et al, 2010; Bowles et al, 2012) and ERK's neuroprotective role in counteracting mHtt toxicity in HD cellular models.